Karin Wuertz-Kozak Headshot

Karin Wuertz-Kozak

Harvey J. Palmer Professor

Department of Biomedical Engineering
Kate Gleason College of Engineering
Affiliated Faculty, Thomas H. Gosnell School of Life Sciences

585-475-7355
Office Hours
Upon Request
Office Location
Office Mailing Address
106 Lomb Memorial Dr.

Karin Wuertz-Kozak

Harvey J. Palmer Professor

Department of Biomedical Engineering
Kate Gleason College of Engineering
Affiliated Faculty, Thomas H. Gosnell School of Life Sciences

Education

BS, MS, University of Regensburg (Germany); Ph.D., University of Ulm (Germany); MBA, University of Cumbria (UK)

Bio

Kate Gleason and Harvey J. Palmer Endowed Professor at Rochester Institute of Technology (RIT) since 2019, appointed following a professorship at ETH Zurich and recipient of the Swiss National Science Foundation Professorship Award (2016). Dr. Karin Wuertz-Kozak is an internationally recognized researcher whose work bridges mechanobiology, tissue engineering, and regenerative medicine to develop clinically relevant strategies for tissue regeneration and pain reduction. She has secured over $9.7M in competitive funding across her career (NIH, NSF, DoD/CDMRP, DARPA, and foundations) and has authored  >110 peer-reviewed publications with ~7,400 citations, reflecting strong impact and sustained productivity.

Her research program is distinguished by bold, forward-looking technology development and rigorous biological translation. The Tissue Regeneration & Mechanobiology (TRAM) Lab integrates human cell and advanced 3D tissue models with extracellular vesicle engineering, CRISPR-based genome manipulation, and precisely controlled mechanical stimulation (e.g., stiffness/topography, stretch, compression) to uncover and modulate drivers of inflammation, degeneration, and fibrosis. Research focuses primarily on musculoskeletal disorders - particularly intervertebral disc degeneration and back pain - while extending mechanistic and regenerative approaches to skin and lung disease. This interdisciplinary approach, spanning engineering, molecular biology, and translational partnerships, positions her work as both high-potential and uniquely scalable toward therapeutic innovation.

Dr. Wuertz-Kozak maintains strong collaborative networks with regional medical centers and national/international institutions, and holds multiple leadership roles in major scientific communities: she was elected Chair of the ORS Spine Section and appointed Deputy Editor of the European Spine Journal (both 2026), and is the only RIT faculty member elected an AIMBE Fellow (2024). She is frequently invited to present her work and reviews regularly for NIH and NSF. Equally central to her impact is her mentorship: her current team comprises 1 postdoc, 6 PhD students, and 7 undergraduates, and over her career she has mentored or co-mentored 30+ PhD trainees and 75+ BS/MS students, with a particular commitment to empowering undergraduates through high-level research experiences. Her mentees have gone on to prestigious opportunities including Fulbright scholarships, an NSF Graduate Research Fellowship (GRFP), medical school, and competitive graduate programs, with many co-authoring peer-reviewed publications

585-475-7355

Areas of Expertise

Select Scholarship

Bermudez-Lekerika P, Crump KB, Wuertz-Kozak K, Le Maitre CL, Gantenbein B: Sulfated hydrogels as primary intervertebral disc cell culture systems. Gels 2024, 10(5), 330

Bjorgvinsdottir O, Ferguson S, Gudjonsson T, Snorradottir B, Wuertz-Kozak K: The Influence of Physical and Spatial Substrate Characteristics on Endothelial Cells. Materials Today Bio 2024, 26: 101060 

Cazzanelli P, Lamoca M, Hausmann ON, Mesfin A, Puvanesarajah V, Hitzl W, Haglund L, Wuertz-Kozak K: Exploring the Impact of TLR-2 Signaling on miRNA Dysregulation in Intervertebral Disc Degeneration. Advanced Biology 2024, 28:e2300581

Ceballos-Santa MC, Sierra A; Zalbidea IK, Lazarus E, Marin-Montealegre V, Ramesh S, Iglesias P, Wuertz-Kozak K, Rivero IV: Aloe vera-based Biomaterial Ink for 3D Bioprinting of Wound Dressing Constructs. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2024, 112(2), e3579

Bitterli T, Schmid D, Ettinger L, Krupkova O, Bach FC, Tryfonidou MA, Meij BP, Pozzi P, Steffen F, Wuertz???Kozak K, Smolders LA: Targeted screening of inflammatory mediators in spontaneous degenerative disc disease in dogs reveals an upregulation of the tumor necrosis superfamily. JOR Spine 2024, 7 (1) e1292

Schoeller J, Wuertz-Kozak K, Ferguson SJ, Rottmar M, Elbs-Glatz Y, Avaro J, Chung M, Rossi RM: Ibuprofen-loaded electrospun poly (ethylene-co-vinyl alcohol) nanofibers for wound dressing applications. Nanoscale Advances 2023, 5 (8) 2261-2270

Currently Teaching

BIME-270
3 Credits
This course is intended to provide an overview of materials used in biomedical applications, both internal and external to the human body. The specific objective of this course is to present the principles which apply to the properties and selection of materials used in medical applications. Topics include an introduction to deformable mechanics and viscoelasticity; structure and properties of metals, ceramics, polymers, and composites; fundamental composition of biological tissues; and principles associated with the interaction between biological tissues and artificial materials.
BIME-499
0 Credits
One semester of paid work experience in biomedical engineering.
BIME-617
3 Credits
This course will present the principles and fundamentals of medical device and in vitro diagnostic regulation. The course will cover the history of the FDA and the regulations around food, drug and cosmetic products. An overview of regulatory pathways, clinical trials, good manufacturing practices and quality system design will be covered. Comparisons between US, EU and other international regulatory bodies will also be discussed. The course will culminate with students developing a clinical trial and regulatory strategy for a new hypothetical medical device.
BIME-670
3 Credits
This is a course with lecture and seminar components. The lecture component will provide a state-of-the-art overview of how replacement organs and tissues can be engineered using both natural and synthetic biomaterials as well as chemical and physical cues that direct cellular differentiation and integration. Furthermore, techniques commonly employed in tissue engineering research are discussed. In the seminar component, students will review and present current journal articles and will listen to research talks given by experts in the field of tissue engineering. Scientific interaction with the presenting researchers in the form of Q&A sessions is expected. Additionally, the course will train students in grant proposal writing.
BIME-675
3 Credits
This hands-on course gives engineering students experience with advanced, state of the art production and application of biomaterials, cell culture methods and analysis techniques used in the area of tissue engineering. In this project-based course, students will work on experiments relating to current literature and will learn how to critically analyze and scientifically summarize the obtained results. Students will use their knowledge and experience to finally design and conduct their independent experiment related to broadly defined topics in the area of tissue engineering.

In the News

  • March 17, 2026

    two women stand next to each other in a research lab with one of them holding a pipette.

    RIT research could slow fibrosis disease progression

    Researchers in RIT's Tissue Regeneration and Mechanobiology Lab are investigating a new approach that could change how fibrosis is treated across organs in patients suffering from systemic sclerosis: targeting the protein TRPC6, a small ion channel—that can sense mechanical cues such as stiffness.
  • September 1, 2023

    two researchers standing next to each other in a lab.

    RIT researchers pioneer solutions for degenerative disc disease and back pain

    Researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S. Using state-of-the-art gene editing technology in mesenchymal stem cells, the researchers will add to the growing field of regenerative medicine, the process of producing cellular therapies to alleviate pain and lack of mobility.